Challenges for Drug Repurposing in Covid-19


The corona virus disease (COVID-19) contagion has affected an estimated 16 million persons and caused 0.6 million deaths worldwide by September 2020. The contagion has led to a rush to repurpose existing drugs, although the elementary substantiation base is of variable quality. The enriching knowledge of the virology and clinical presentation of COVID-19 is leading to a broadening pool of implicit pharmacological targets. The intention is to describe executive and pharmacological aspects of medicine repurposing and to identify medicines proposed for repurposing in COVID-19 hung on registered clinical trials, bandying the substantiation to support their use in the treatment of this distemper. The challenges of the correct interpretation of breathing pre-clinical/ clinical substantiation as well as the generation of new substantiation concerning medicine repurposing in COVID-19 will also be agitated


  • SARS-CoV-2 Mpro
  • Functional Fine-Tuning of Metabolic Pathways by the Endocannabinoid System-Implications for Health and Disease.
  • Cytokine storm modulation in COVID-19: a proposed role for vitamin D and DPP-4 inhibitor combination therapy (VIDPP-4i)
  • Drug Repurposing in the COVID-19 Era

Related Conference of Challenges for Drug Repurposing in Covid-19

August 18-19, 2025

40th World Congress on Pharmacology and Therapeutics

Valencia, Spain
August 27-28, 2025

20th World Congress on Drug Formulation & Drug Delivery

Amsterdam, Netherlands
September 19-20, 2025

18th World Drug Delivery Summit

Paris, France
September 22-23, 2025

Pharma Biotech Expo

Toronto, Canada
September 23-24, 2025

10th International Conference on Future Pharma and Innovations

Amsterdam, Netherlands
September 24-25, 2025

5th World Congress on Rare Diseases & Orphan Drugs

Aix-en-Provence, France
October 23-24, 2025

21st Annual Meet on Pharmaceutical Sciences

Aix-en-Provence, France
November 11-12, 2025

6th Annual Congress on Antibiotics and Bacterial Infections

Amsterdam, Netherlands
November 13-14, 2025

21st International Conference on Pharmaceutical Chemistry

Aix-en-Provence, France
November 20-21, 2025

21st Annual Congress on Pharmacology and Toxicology

Paris, France
November 27-28, 2025

4th World Congress on Precision and Personalized Medicine

Zurich, Switzerland
November 27-28, 2025

4th World Conference on Pharma Industry and Medical Devices

Zurich, Switzerland
November 27-28, 2025

13th International Conference on Clinical Trials

Amsterdam, Netherlands
February 23-24, 2026

3rd World Congress on Biologics and Biosimilars

London, Aland Islands
April 27-28, 2026

9th European Biopharma Congress

Paris, Aland Islands

Challenges for Drug Repurposing in Covid-19 Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in